FindTrial
Sign In

Clinical effect of atoxiban on selective single embryo transfer

Clinical effect of atoxiban on selective single embryo transfer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056942
Enrollment
Unknown
Registered
2022-02-23
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sterility

Interventions

Group Atosiban:Atosiban
Control:None

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1.Age 20-38 years; 2.The number of excellent embryos that can be transplanted in the selection cycle is >= 2; 3.One high-quality embryo was transplanted in the selected cycle.

Exclusion criteria

Exclusion criteria: 1. Abnormal uterine development, severe pelvic adhesions, uterine fibroids and adenomyosis; 2. Endocrine diseases (hyperthyroidism, hypothyroidism, hyperprolactinemia, etc.); 3. Hydrosalpinx; 4. Chromosome abnormality; 5. Previous history of recurrent abortion.

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate;—

Countries

China

Contacts

Public ContactZhang Xuanlin

Tianjin First Central Hospital

zhangxl1218@163.com+86 18202297693

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026